Multi-Branch High-Dimensional Guided Transformer-Based 3D Human Posture Estimation

The human pose paradigm is estimated using a transformer-based multi-branch multidimensional directed the three-dimensional(3D)method that takes into account self-occlusion,badly posedness,and a lack of depth data in the per-frame 3D posture estimation from two-dimensional(2D)mapping to 3D mapping.Firstly,by examining the relationship between the movements of different bones in the human body,four virtual skeletons are proposed to enhance the cyclic constraints of limb joints.Then,multiple parameters describing the skeleton are fused and projected into a high-dimensional space.Utilizing a multi-branch network,motion features between bones and overall motion features are extracted to mitigate the drift error in the estimation results.Furthermore,the estimated relative depth is projected into 3D space,and the error is calculated against real 3D data,forming a loss function along with the relative depth error.This article adopts the average joint pixel error as the primary performance metric.Compared to the benchmark approach,the estimation findings indicate an increase in average precision of 1.8 mm within the Human3.6M sample.

BIRC3 induces the phosphoinositide 3-kinase-Akt pathway activation to promote trastuzumab resistance in human epidermal growth factor receptor 2-positive gastric cancer

BACKGROUND Trastuzumab-targeted therapy is currently the standard of care for advanced human epidermal growth factor receptor 2(HER2)-positive gastric cancer.However,the emergence of resistance to trastuzumab poses significant challenges.AIM To identify the key genes associated with trastuzumab resistance.These results provide a basis for the development of interventions to address drug resistance and improve patient outcomes.METHODS High-throughput sequencing and bioinformatics were used to identify the differentially expressed pivotal gene BIRC3 and delineate its potential function and pathway regulation.Tumor samples were collected from patients with HER2-positive gastric cancer to evaluate the correlation between BIRC3 expression and trastuzumab resistance.We established gastric cancer cell lines with both highly expressed and suppressed levels of BIRC3,followed by comprehensive in vitro and in vivo experiments to confirm the involvement of BIRC3 in trastuzumab resistance and to elucidate its underlying mechanisms.RESULTS In patients with HER2-positive gastric cancer,there is a significant correlation between elevated BIRC3 expression in tumor tissues and higher T stage,tumor node metastasis stage,as well as poor overall survival and progressionfree survival.BIRC3 is highly expressed in trastuzumab-resistant gastric cancer cell lines,where it inhibits tumor cell apoptosis and enhances trastuzumab resistance by promoting the phosphorylation and activation of the phosphoinositide 3-kinase-Akt(PI3K-AKT)pathway in HER2-positive gastric cancer cells,both in vivo and in vitro.CONCLUSION This study revealed a robust association between high BIRC3 expression and an unfavorable prognosis in patients with HER2-positive gastric cancer.Thus,the high expression of BIRC3 stimulated PI3K-AKT phosphorylation and activation,stimulating the proliferation of HER2-positive tumor cells and suppressing apoptosis,ultimately leading to trastuzumab resistance.

Effects of interleukin-10 treated macrophages on bone marrow mesenchymal stem cells via signal transducer and activator of transcription 3 pathway

BACKGROUND Alveolar bone defects caused by inflammation are an urgent issue in oral implant surgery that must be solved.Regulating the various phenotypes of macrophages to enhance the inflammatory environment can significantly affect the progression of diseases and tissue engineering repair process.AIM To assess the influence of interleukin-10(IL-10)on the osteogenic differentiation of bone marrow mesenchymal stem cells(BMSCs)following their interaction with macrophages in an inflammatory environment.METHODS IL-10 modulates the differentiation of peritoneal macrophages in Wistar rats in an inflammatory environment.In this study,we investigated its impact on the proliferation,migration,and osteogenesis of BMSCs.The expression levels of signal transducer and activator of transcription 3(STAT3)and its activated form,phos-phorylated-STAT3,were examined in IL-10-stimulated macrophages.Subsequently,a specific STAT3 signaling inhibitor was used to impede STAT3 signal activation to further investigate the role of STAT3 signaling.RESULTS IL-10-stimulated macrophages underwent polarization to the M2 type through substitution,and these M2 macrophages actively facilitated the osteogenic differentiation of BMSCs.Mechanistically,STAT3 signaling plays a crucial role in the process by which IL-10 influences macrophages.Specifically,IL-10 stimulated the activation of the STAT3 signaling pathway and reduced the macrophage inflammatory response,as evidenced by its diminished impact on the osteogenic differentiation of BMSCs.CONCLUSION Stimulating macrophages with IL-10 proved effective in improving the inflammatory environment and promoting the osteogenic differentiation of BMSCs.The IL-10/STAT3 signaling pathway has emerged as a key regulator in the macrophage-mediated control of BMSCs’osteogenic differentiation.

Intelligent 3D garment system of the human body based on deep spiking neural network

Background Intelligent garments,a burgeoning class of wearable devices,have extensive applications in domains such as sports training and medical rehabilitation.Nonetheless,existing research in the smart wearables domain predominantly emphasizes sensor functionality and quantity,often skipping crucial aspects related to user experience and interaction.Methods To address this gap,this study introduces a novel real-time 3D interactive system based on intelligent garments.The system utilizes lightweight sensor modules to collect human motion data and introduces a dual-stream fusion network based on pulsed neural units to classify and recognize human movements,thereby achieving real-time interaction between users and sensors.Additionally,the system incorporates 3D human visualization functionality,which visualizes sensor data and recognizes human actions as 3D models in real time,providing accurate and comprehensive visual feedback to help users better understand and analyze the details and features of human motion.This system has significant potential for applications in motion detection,medical monitoring,virtual reality,and other fields.The accurate classification of human actions contributes to the development of personalized training plans and injury prevention strategies.Conclusions This study has substantial implications in the domains of intelligent garments,human motion monitoring,and digital twin visualization.The advancement of this system is expected to propel the progress of wearable technology and foster a deeper comprehension of human motion.

NRG1、HER3在前列腺癌组织中的表达及其与临床病理特征和预后的关系

目的研究前列腺癌(PC)组织中神经调节蛋白1(NRG1)、人表皮生长因子受体3(HER3)表达与临床病理特征及预后的关系。方法选取2015年2月—2020年2月吉林省人民医院泌尿外科诊治PC患者96例,免疫组织化学检测组织中NRG1、HER3表达;Kaplan-Meier曲线(Log-Rank检验)比较不同NRG1、HER3表达对PC患者预后的影响;COX回归分析PC患者预后的影响因素。结果PC癌组织中NRG1、HER3阳性率分别为78.13%(75/96)、75.00%(72/96),高于癌旁组织6.25%(6/96)、8.33%(8/96)(χ^(2)/P=101.670/<0.001,87.771/<0.001)。TNM分期Ⅲ期、Gleason评分>7分及术前PSA水平≥20μg/L患者癌组织中NRG1、HER3阳性率大于TNM分期Ⅰ~Ⅱ期、Gleason评分≤7分及术前PSA水平<20μg/L(χ^(2)/P=6.181/0.013,8.533/0.003;7.731/0.005,6.769/0.009;6.508/0.011,7.376/0.007)。NRG1阳性组、HER3阳性组3年累积无进展生存率分别低于NRG1阴性组、HER3阴性组(χ^(2)/P=4.267/0.039,5.499/0.019)。TNM分期Ⅲ期、Gleason评分>7分、术前PSA≥20μg/L、NRG1阳性,HER3阳性是影响PC患者预后的独立危险因素[OR(95%CI)=1.448(1.118~1.875),1.401(1.138~1.724),1.353(1.059~1.728),1.338(1.057~1.692),1.293(1.014~1.649)]。结论PC癌组织中NRG1、HER3表达升高,与PC不良临床病理特征相关,是新的评估PC预后的肿瘤标志物。

泄浊养血法联合重组人促红素注射液治疗肾虚湿浊型慢性肾脏病3~5期肾性贫血患者的临床观察

[目的]观察泄浊养血法联合重组人促红素注射液对慢性肾脏病(CKD)3~5期肾性贫血患者贫血改善及残余肾功能的干预作用。[方法]选择2020年10月—2021年10月就诊于天津中医药大学第一附属医院的88例CKD 3~5期肾性贫血患者,根据随机数字表法随机分为对照组(44例)和治疗组(44例)。对照组予重组人促红细胞生成素注射液及多糖铁复合物治疗,治疗组在此基础上联合泄浊养血法中药方治疗,连续服用3个月,观察治疗前后两组临床疗效、红细胞计数(RBC)、血红蛋白(Hb)、血清肌酐(Scr)、尿素氮(BUN)、肾小球滤过率(eGFR)、尿微量白蛋白(mALB)、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)的变化,症状积分及不良反应发生率。[结果]治疗3个月后,治疗组总有效率为86.36%,对照组为56.82%,治疗组临床疗效优于对照组(P<0.05);症状积分、RBC、Hb、Scr、BUN、mALB均较治疗前改善,且治疗组优于对照组(P<0.05);安全性指标中AST、ALT治疗前后数值变化,差异无统计学意义(P>0.05)。两组病例中均未出现不良反应。[结论]泄浊养血法联合重组人促红细胞生成素注射液治疗可以改善CKD 3~5期非透析肾性贫血患者临床症状,提高临床疗效,延缓肾功能进展,且具有一定的安全性。

Pharmacokinetics of recombinant human interleukin-3 in rhesus monkeys

Concentration-time profiles of ^(125)I-labeled recombinant human interleukin-3 (125IrhIL-3) were de-termined by reverse phase high performance liquid chromatography (RHPLC) after intravenous and subcutaneous ad-ministration of the drug in 16 rhesus monkeys. The initial and terminal T1/2 in plasma after intravenous of 30 μg/kg were (0. 15 ±0.13) and (2. 21 ± 0. 59) h, respectively. Terminal half-lives after 30, 90 and 180μg/kg subcutaneous (s.c.) injections were 2. 0-3.8 h. Area under concentration-time curves (AUC) following s. c. were roughly in-creased with dose, while CL5 were similar among different dosages. The absorption rates were dependent on concentra-tion at injected site. Bioavailability was about 0.7 after s.c. Rapid biodegradation was found in plasma. Distribution profiles of total radioactivity were as follows: the highest level was found in urinary system; levels in bile-enteric sys-tem, lymph nodes, bone marrow and spleen were near to that in plasma, and level in brain was the lowest. The RH-PLC analysis revealed that kidney was one of the major organs for biodegradation.

右美托咪定下调PI3K/AKT信号通路改善脂多糖诱导的结肠炎结肠上皮细胞损伤

为研究右美托咪定对脂多糖(LPS)诱导的人结肠上皮NCM-460细胞的炎症、增殖和凋亡的影响及磷脂酰肌醇-3-激酶/丝氨酸-苏氨酸激酶(PI3K/AKT)信号通路的调控作用,本研究体外培养人结肠上皮NCM-460细胞,将其分为对照组、LPS组(1μg/mL LPS)和不同质量浓度右美托咪定组(1μg/mL LPS+1.25、2.50、5.00和10.00μg/mL右美托咪定),干预24 h,筛选出合适的右美托咪定作用质量浓度用于后续试验。随后,将人结肠上皮NCM-460细胞分为对照组、LPS组、右美托咪定组(1μg/mL LPS+5.00μg/mL右美托咪定)、LY294002组(1μg/mL LPS+10μmol/L PI3K/AKT通路抑制剂LY294002)、抑制剂组(1μg/mL LPS+5.00μg/mL右美托咪定+10μmol/L LY294002)和激活剂组(1μg/mL LPS+5.00μg/mL右美托咪定+10μmol/L PI3K/AKT通路激动剂SC79),干预24 h。用细胞计数试剂盒-8(CCK-8)检测细胞活力;通过酶联免疫吸附试验(ELISA)检测肿瘤坏死因子-α(TNF-α)和白细胞介素-8(IL-8)的表达水平;用5-乙炔基-2'脱氧尿嘧啶核苷(EdU)测定细胞增殖率;用Hoechst 33258染色法测定细胞凋亡率;用蛋白免疫印迹(WB)法测定细胞周期蛋白D1(Cyclin D1)、剪切的半胱氨酸蛋白酶-3(cleaved Caspase 3)和PI3K/AKT信号通路关键蛋白的表达水平。根据细胞活力和炎症因子TNF-α的表达水平选择5.00μg/mL右美托咪定用于后续试验。结果显示,与对照组相比,LPS组细胞增殖率和Cyclin D1的表达水平显著降低(P<0.05),细胞凋亡率、TNF-α、IL-8、cleaved Caspase 3的表达水平、p-PI3K/PI3K及p-AKT/AKT的比值显著升高(P<0.05);右美托咪定组和LY294002组中的右美托咪定和LY294002扭转了LPS对人结肠上皮NCM-460细胞的上述作用(P<0.05);与右美托咪定组相比,抑制剂组中的LY294002增强了右美托咪定对LPS诱导的人结肠上皮NCM-460细胞的作用(P<0.05),激活剂组中的SC79则削弱了右美托咪定对LPS诱导的人结肠上皮NCM-460细胞的作用(P<0.05)。研究表明,右美托咪定能促进LPS诱导的人结肠上皮NCM-460细胞增殖,抑制其炎症和凋亡,其作用机制可能与阻滞PI3K/PI3K信号通路信号转导有关。本研究为结肠炎的治疗提供了新的方向。

环状RNA同源性蛋白激酶3靶向微RNA-338促进胶质瘤细胞侵袭、迁移的实验研究

目的探讨人血清环状RNA同源性蛋白激酶3(CircHIPK3)靶向微RNA-338(miR-338)对胶质瘤细胞U251细胞侵袭、迁移的影响。方法2021年2-12月,在武汉大学人民医院科研中心将U251细胞分为空白(NG)组、CircHIPK3阴性对照(shcontrol)组、HIPK3敲减(sh-CircHIPK3)组,实时荧光定量PCR(qRT-PCR)检测U251细胞中CircHIPK3、miR-338表达水平;Transwell检测细胞迁移与侵袭;划痕法检测细胞迁移;流式细胞术检测细胞周期;通过Circular RNA Interactome、RegRNA2.0、CircBank Database网站预测CircHIPK3(ID:hsa_circ_0000284)的靶向miRNA并用双萤光素酶实验验证,蛋白质印迹法检测基质金属蛋白酶(MMP)-2、MMP-9蛋白表达。结果与NG组、sh-control组比较,sh-CircHIPK3组中CircHIPK3(1.00±0.00、1.06±0.26比0.56±0.06)表达水平显著降低(P<0.05),miR-338(1.00±0.00、1.12±0.19比1.89±0.28)表达、G1期细胞比例[(58.72±0.36)%、(58.45±0.27)%比(64.72±0.47)%]升高(P<0.05),U251细胞侵袭数目[(164.89±12.55)个、(165.77±12.16)个比(80.13±11.37)个]、划痕愈合率[(25.66±2.37)%、(26.38±2.53)%比(10.36±1.53)%]、迁移细胞数目[(196.72±18.75)个、(194.65±17.86)个比(95.58±8.66)个]、S期细胞比例[(26.45±0.39)%、(26.57±0.41)%比(20.72±0.18)%]明显降低(P<0.05);miR-338是CircHIPK3的靶基因。与NG组、sh-control组比较,sh-CircHIPK3组MMP-2(1.31±0.23、1.33±0.20比0.61±0.05)、MMP-9(1.16±0.22、1.15±0.21比0.85±0.19)蛋白表达水平均显著降低(P<0.05)。结论沉默CircHIPK3通过靶向上调miR-338表达能抑制胶质瘤细胞U251细胞迁移和侵袭。

四氢嘧啶对HaCaT细胞活力及AQP3、Claudin-1、ZO-1表达的影响

目的研究四氢嘧啶(Ectoine)对人角质形成细胞(HaCaT)的细胞活力、细胞凋亡率和细胞活性氧(ROS)的影响,并分析水通道蛋白3(AQP3)、紧密连接蛋白-1(Claudin-1)、闭锁连接蛋白(ZO-1)的表达水平。方法设置Ectoine浓度实验组和空白对照组,培养HaCaT细胞(24 h),采用CCK8法检测HaCaT细胞的细胞活力,甄选最佳的Ectoine作用浓度。用Western Blot法检测HaCaT细胞的AQP3、Claudin-1、ZO-1表达水平;用流式细胞仪检测HaCaT细胞的凋亡率及胞内ROS水平。结果CCK8法检测结果显示,0.10%Ectoine组、0.20%Ectoine组、0.30%Ectoine组的HaCaT细胞活力均高于120%,其中0.20%Ectoine组最高(146.92%±7.67%)。Ectoine浓度实验组相对于空白对照组,HaCaT细胞的AQP3、Claudin-1、ZO-1表达水平明显升高(P<0.05),且细胞凋亡率和胞内ROS水平均明显降低(P<0.05)。结论Ectoine可提高HaCaT细胞的细胞活力,降低凋亡率和胞内ROS水平,上调AQP3、Claudin-1、ZO-1表达水平。Ectoine可能与相关保湿蛋白的表达相关,对HaCaT细胞具有一定的保护作用。

GATA3介导miR-21/PTEN轴对子宫内膜癌细胞增殖、侵袭的影响

目的分析GATA结合蛋白3(GATA3)介导微小RNA-21(miR-21)/人类第10号染色体缺失的磷酸酶及张力蛋白同源物(PTEN)轴对子宫内膜癌细胞增殖、侵袭的影响。方法取HEC-1-A细胞,进行转染分组,分为对照组、GATA3空载质粒组、GATA3过表达质粒组、GATA3 siRNA阴性对照组、GATA3 siRNA组。检测各组细胞中GATA3、miR-21、PTEN表达量、增殖情况、凋亡率、迁移、侵袭。结果与hEEC组相比,HEC-1-A组、HEC-1-B组、Ishikawa组细胞中GATA3、miR-21表达水平升高,PTEN表达水平降低(P<0.05)。与GATA3空载质粒组相比,GATA3过表达质粒组GATA3、miR-21 mRNA表达量、增殖率、迁移距离、侵袭细胞数、Vimentin水平升高,PTEN mRNA表达量、凋亡率、Caspase-9、Bax、E-cadherin水平降低(P<0.05);与GATA3 siRNA阴性对照组相比,GATA3、miR-21 mRNA表达量、增殖率、迁移距离、侵袭细胞数、Vimentin水平降低,PTEN mRNA表达量、凋亡率、Caspase-9、Bax、E-cadherin水平升高(P<0.05)。结论下调GATA3表达,可对miR-21/PTEN轴进行调节,使HEC-1-A细胞的增殖减慢,促进HEC-1-A细胞的凋亡。

Overview of 3D Human Pose Estimation

3D human pose estimation is a major focus area in the field of computer vision,which plays an important role in practical applications.This article summarizes the framework and research progress related to the estimation of monocular RGB images and videos.An overall perspective ofmethods integrated with deep learning is introduced.Novel image-based and video-based inputs are proposed as the analysis framework.From this viewpoint,common problems are discussed.The diversity of human postures usually leads to problems such as occlusion and ambiguity,and the lack of training datasets often results in poor generalization ability of the model.Regression methods are crucial for solving such problems.Considering image-based input,the multi-view method is commonly used to solve occlusion problems.Here,the multi-view method is analyzed comprehensively.By referring to video-based input,the human prior knowledge of restricted motion is used to predict human postures.In addition,structural constraints are widely used as prior knowledge.Furthermore,weakly supervised learningmethods are studied and discussed for these two types of inputs to improve the model generalization ability.The problem of insufficient training datasets must also be considered,especially because 3D datasets are usually biased and limited.Finally,emerging and popular datasets and evaluation indicators are discussed.The characteristics of the datasets and the relationships of the indicators are explained and highlighted.Thus,this article can be useful and instructive for researchers who are lacking in experience and find this field confusing.In addition,by providing an overview of 3D human pose estimation,this article sorts and refines recent studies on 3D human pose estimation.It describes kernel problems and common useful methods,and discusses the scope for further research.

Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome

BACKGROUND Diabetic cardiomyopathy(DCM),which is a complication of diabetes,poses a great threat to public health.Recent studies have confirmed the role of NLRP3(NOD-like receptor protein 3)activation in DCM development through the inflammatory response.Teneligliptin is an oral hypoglycemic dipeptidyl peptidase-IV inhibitor used to treat diabetes.Teneligliptin has recently been reported to have anti-inflammatory and protective effects on myocardial cells.AIM To examine the therapeutic effects of teneligliptin on DCM in diabetic mice.METHODS Streptozotocin was administered to induce diabetes in mice,followed by treatment with 30 mg/kg teneligliptin.RESULTS Marked increases in cardiomyocyte area and cardiac hypertrophy indicator heart weight/tibia length reductions in fractional shortening,ejection fraction,and heart rate;increases in creatine kinase-MB(CK-MB),aspartate transaminase(AST),and lactate dehydrogenase(LDH)levels;and upregulated NADPH oxidase 4 were observed in diabetic mice,all of which were significantly reversed by teneligliptin.Moreover,NLRP3 inflammasome activation and increased release of interleukin-1βin diabetic mice were inhibited by teneligliptin.Primary mouse cardiomyocytes were treated with high glucose(30 mmol/L)with or without teneligliptin(2.5 or 5μM)for 24 h.NLRP3 inflammasome activation.Increases in CKMB,AST,and LDH levels in glucose-stimulated cardiomyocytes were markedly inhibited by teneligliptin,and AMP(p-adenosine 5‘-monophosphate)-p-AMPK(activated protein kinase)levels were increased.Furthermore,the beneficial effects of teneligliptin on hyperglycaemia-induced cardiomyocytes were abolished by the AMPK signaling inhibitor compound C.CONCLUSION Overall,teneligliptin mitigated DCM by mitigating activation of the NLRP3 inflammasome.

3D Human Pose Estimation Using Two-Stream Architecture with Joint Training

With the advancement of image sensing technology, estimating 3Dhuman pose frommonocular video has becomea hot research topic in computer vision. 3D human pose estimation is an essential prerequisite for subsequentaction analysis and understanding. It empowers a wide spectrum of potential applications in various areas, suchas intelligent transportation, human-computer interaction, and medical rehabilitation. Currently, some methodsfor 3D human pose estimation in monocular video employ temporal convolutional network (TCN) to extractinter-frame feature relationships, but the majority of them suffer from insufficient inter-frame feature relationshipextractions. In this paper, we decompose the 3D joint location regression into the bone direction and length, wepropose the TCG, a temporal convolutional network incorporating Gaussian error linear units (GELU), to solvebone direction. It enablesmore inter-frame features to be captured andmakes the utmost of the feature relationshipsbetween data. Furthermore, we adopt kinematic structural information to solve bone length enhancing the use ofintra-frame joint features. Finally, we design a loss function for joint training of the bone direction estimationnetwork with the bone length estimation network. The proposed method has extensively experimented on thepublic benchmark dataset Human3.6M. Both quantitative and qualitative experimental results showed that theproposed method can achieve more accurate 3D human pose estimations.

Building 3-D Human Data Based on Handed Measurement and CNN

3-dimension(3-D)printing technology is growing strongly with many applications,one of which is the garment industry.The application of human body models to the garment industry is necessary to respond to the increasing personalization demand and still guarantee aesthetics.This paper proposes amethod to construct 3-D human models by applying deep learning.We calculate the location of the main slices of the human body,including the neck,chest,belly,buttocks,and the rings of the extremities,using pre-existing information.Then,on the positioning frame,we find the key points(fixed and unaltered)of these key slices and update these points tomatch the current parameters.To add points to a star slice,we use a deep learning model tomimic the form of the human body at that slice position.We use interpolation to produce sub-slices of different body sections based on the main slices to create complete body parts morphologically.We combine all slices to construct a full 3-D representation of the human body.

Implementation of Level-3 Autonomous Patient-Specific Quality Assurance with Automated Human Interactive Devices

Purpose: Patient-specific quality assurance (PSQA) requires manual operation of different workstations, which is time-consuming and error-prone. Therefore, developing automated solutions to improve efficiency and accuracy is a priority. The purpose of this study was to develop a general software interface with scripting on a human interactive device (HID) for improving the efficiency and accuracy of manual quality assurance (QA) procedures. Methods: As an initial application, we aimed to automate our PSQA workflow that involves Varian Eclipse treatment planning system, Elekta MOSAIQ oncology information system and PTW Verisoft application. A general platform, the AutoFrame interface with two imbedded subsystems—the AutoFlow and the PyFlow, was developed with a scripting language for automating human operations of aforementioned systems. The interface included three functional modules: GUI module, UDF script interpreter and TCP/IP communication module. All workstations in the PSQA process were connected, and most manual operations were automated by AutoFrame sequentially or in parallel. Results: More than 20 PSQA tasks were performed both manually and using the developed AutoFrame interface. On average, 175 (±12) manual operations of the PSQA procedure were eliminated and performed by the automated process. The time to complete a PSQA task was 8.23 (±0.78) minutes for the automated workflow, in comparison to 13.91 (±3.01) minutes needed for manual operations. Conclusion: We have developed the AutoFrame interface framework that successfully automated our PSQA procedure, and significantly reduced the time, human (control/clicking/typing) errors, and operators’ stress. Future work will focus on improving the system’s flexibility and stability and extending its operations to other QA procedures.

PTCSC3对谷氨酸诱导SH-SY5Y神经细胞凋亡的影响

目的探讨乳头状甲状腺癌易感性候选基因3(papillary thyroid carcinoma susceptibility candidate 3,PTCSC3)对谷氨酸(glutamicacid,Glu)诱导人神经母细胞瘤细胞(SH-SY5Y)凋亡的影响及其机制。方法体外培养SH-SY5Y细胞,谷氨酸损伤SH-SY5Y细胞24 h,转染技术对PTCSC3进行抑制及过表达,采用Hoechst 33258染色法、流式细胞技术、AO/EB染色及四甲基偶氮唑盐比色(methylthiazolyl tetrazolium,MTT)法检测抑制或过表达PTCSC3后对各组细胞凋亡、生存的影响;实时荧光定量PCR(quantitative real-time PCR,qPCR)技术检测各组细胞中PTCSC3、CCAAT/增强子结合蛋白β(CAAT/enhancer binding protein beta,C/EBP-β)及Cbp/p300结合转化激活因子4(Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4,CITED4)的基因表达情况;Western blot检测各组细胞中C/EBP-β、脑源性神经营养因子(brain-derived neurotrophic factor,BDNF)、蛋白激酶B(protein kinase B,Akt)、B淋巴细胞瘤-2(B-cell lymphoma-2,Bcl-2)、Bcl-2相关X蛋白(Bcl-2 associated X protein,Bax)及CITED4、细胞周期蛋白D1(Cyclin D1)、原癌基因n-Myc的蛋白表达水平。结果2000μmol·L^(-1)Glu处理24 h对PTCSC3细胞有明显的损伤作用;与模型组比较,PTCSC3抑制剂可有效改善Glu诱导SH-SY5Y细胞凋亡率的增加和细胞存活率的下降;明显降低C/EBP-β基因及蛋白、Bax蛋白的表达,促进BDNF、p-Akt、Bcl-2蛋白的表达;增加CITED4、Cyclin D1和n-Myc的表达水平。反之,过表达PTCSC3则出现与上述结果相反的结果。结论PTCSC3可能通过调控C/EBP-β,进而调控下游信号通路BDNF/Akt和CITED4/Cyclin D1信号通路,改善Glu诱导SH-SY5Y神经细胞的凋亡和生存状态。

PIK3CA突变与乳腺癌临床病理特征及预后的相关性

目的探讨乳腺癌标本中磷脂酰肌醇激酶-3-催化亚基α(PIK3CA)突变与侵袭性乳腺癌临床病理特征及预后的相关性。方法收集2018年1月至2020年1月确诊为乳腺癌的181例患者临床病理资料,用免疫组织化学(IHC)法检测乳腺癌雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER2)、Ki-67等指标,RT-qPCR检测乳腺癌中PIK3CA外显子9(exon9)和外显子20(exon20)的突变。结果181例侵袭性乳腺癌中PIK3CA突变70例,其中31例(44.28%)exon9突变、39例(55.71%)exon20突变。PIK3CA突变与乳腺癌分子分型有明显差异(P<0.05)。PIK3CA突变与乳腺癌的Ki67表达有明显差异(P<0.05)。34例(48.57%)HR+/HER2-组PIK3CA突变,36例(51.43%)非HR+/HER2-组突变,二者PIK3CA突变分布有明显差异(P<0.05)。PIK3CA突变患者病死率高于PIK3CA野生型(P<0.05)。结论PIK3CA突变与乳腺癌分子分型、Ki67增值指数及预后相关,可为患者精准治疗提供参考。

高原地区不同程度冠状动脉狭窄与EGR3、VEGF蛋白的相关性分析

目的对不同程度冠状动脉(简称冠脉)狭窄与人早期生长反应因子3(early growth response 3,EGR3)、血管内皮生长因子(vascular endothelial growth factor,VEGF)等蛋白因子的相关性进行探讨,同时筛选出与EGR3、VEGF相关性最强的蛋白因子,并探讨高原地区快速诊断冠心病以及评估冠脉狭窄程度潜在的新生物标志物。方法选取青海省人民医院(海拔2260 m)心内科住院患者172例,根据冠脉狭窄程度将其分为病例组126例(包括动脉粥样硬化组38例、中度狭窄组71例、重度狭窄组17例)和对照组46例。检测EGR3、VEGF等蛋白因子并进行统计学分析,再借助京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)分析,探讨高原地区快速诊断冠心病以及评估冠脉狭窄程度潜在的新生物标志物。结果动脉粥样硬化组、中度狭窄组、重度狭窄组的人单核细胞/巨核细胞主要组织相容性复合体受体1(human monocyte/megakaryocyte major histocompatibility complex receptor 1,MMR1)、EGR3、人血栓素B2(thromboxane B2,TXB2)、人血清反应因子(serum response factor,SRF)、人血小板活化因子(platelet activating factor,PAF)、VEGF、人cAMP反应元件结合蛋白(cyclic-AMP response element binding protein,CREB)、人血小板生成素(thrombopoietin,TPO)、人血小板反应蛋白/凝血酶敏感蛋白1(thrombospondin 1,THBS1)水平与对照组比较,差异均有统计学意义(均P<0.05)。Spearman相关性分析显示,血清VEGF与TXB2、SRF、PAF、EGR3、CREB、TPO、THBS1均呈正相关(r=0.460、0.644、0.539、0.462、0.740、0.702、0.673,均P<0.05),以血清CREB与VEGF相关性最强。血清EGR3与MMR1、TXB2、SRF、PAF、VEGF、CREB、TPO、THBS1均呈正相关(r=0.405、0.682、0.780、0.700、0.462、0.686、0.551、0.245,均P<0.05),以血清SRF与EGR3相关性最强。通过KEGG分析得出,在通路hsa04010中,SRF在VEGF的下游,调控增殖与分化;在通路hsa04926中,CREB在VEGF的上游,调控血管生成;在通路hsa04066中,缺氧诱导因子在VEGF的上游,调控血管的生成。结论因子MMR1、EGR3、TXB2、SRF、PAF、VEGF、CREB、TPO、THBS1与冠脉狭窄严重程度存在相关性,VEGF、CREB、SRF、EGR3可能成为高原地区冠心病诊断新的生物标志物。

人β-防御素3水凝胶治疗大鼠牙周炎

背景:既往研究显示人β-防御素3具有显著的抗真菌、抗细菌和抗病毒活性,并且在连接先天和获得性免疫应答中起到重要的桥梁作用。目的:观察人β-防御素3水凝胶治疗大鼠牙周炎的效果。方法:以泊洛沙姆188与407为基质,采用冷溶法构建空白水凝胶,将人β-防御素3与该水凝胶混合制备人β-防御素3水凝胶。将25只SD大鼠随机分为5组,每组5只:健康组不做任何处理,牙周炎组、空白水凝胶组、盐酸米诺环素组、载药水凝胶组采用正畸结扎钢丝法构建牙周炎模型,造模8周后于颊侧与腭侧牙周袋内分别注射空白水凝胶、盐酸米诺环素、人β-防御素3水凝胶,1次/周,连续给药4周后进行相关检测。结果与结论:①与健康组比较,牙周炎组大鼠牙周菌斑指数、牙龈出血指数及牙周探诊深度均增加(P<0.01);与牙周炎组比较,盐酸米诺环素组与载药水凝胶组大鼠牙周菌斑指数、牙龈出血指数及牙周探诊深度均减少(P<0.05);②大鼠脏器苏木精-伊红染色显示载药水凝胶无毒性作用;③体视显微镜与Micro CT扫描显示,与健康组比较,牙周炎组大鼠牙根暴露及釉牙骨质界-牙槽嵴顶距离均增加(P<0.05);与牙周炎组比较,盐酸米诺环素组与载药水凝胶组大鼠牙根暴露、釉牙骨质界-牙槽嵴顶距离均减少(P<0.05);④苏木精-伊红、Masson及抗酒石酸酸性磷酸酶染色显示,牙周炎组、空白水凝胶组大鼠牙周炎症明显、纤维结构混乱、破骨细胞活跃,盐酸米诺环素组、载药水凝胶组大鼠牙周炎症水平降低、纤维排列较规则、破骨细胞减少;⑤qRT-PCR检测显示,与健康组比较,牙周炎组大鼠牙龈组织中白细胞介素1β、肿瘤坏死因子α、白细胞介素6、诱导型一氧化氮合酶的mRNA表达升高(P<0.05);与牙周炎组比较,盐酸米诺环素组、载药水凝胶组大鼠牙龈组织中白细胞介素1β、肿瘤坏死因子α、白细胞介素6、诱导型一氧化氮合酶的mRNA表达降低(P<0.05);⑥结果表明,人β-防御素3水凝胶可通过降低炎症因子的相对表达及抑制破骨来减轻大鼠牙周组织炎症。